Stock DNA
Commodity Chemicals
INR 165 Cr (Micro Cap)
30.00
40
0.27%
-0.14
2.50%
0.76
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-12-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Kanchi Karpooram Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Kanchi Karpooram, a microcap player in the Commodity Chemicals sector, has undergone a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment highlights the evolving challenges faced by the company amid subdued sales growth and valuation concerns.
Read MoreIs Kanchi Karpooram overvalued or undervalued?
As of 17 November 2025, Kanchi Karpooram's valuation grade has moved from attractive to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, with a PE ratio of 30.23, an EV to EBIT of 38.38, and a Price to Book Value of 0.76. These ratios suggest that the stock is trading at a premium compared to its earnings and book value. In comparison to its peers, Kanchi Karpooram's PE ratio is lower than Solar Industries at 95.31 and Gujarat Fluoroch at 57.85, but it is still elevated given its own financial performance, particularly with a ROCE of only 1.87% and a ROE of 2.50%. The company's recent stock performance has been poor, with a year-to-date return of -30.80%, significantly underperforming the Sensex, which has returned 8.72% over the same period. This further reinforces the conclusion that Kanchi Karpooram is overvalued in the current market environm...
Read More
Kanchi Karpooram Q2 FY26: Profit Plunge Deepens as Margins Collapse
Kanchi Karpooram Ltd., a micro-cap commodity chemicals manufacturer, reported a consolidated net profit of ₹1.87 crores for Q2 FY26, marking a steep 73.88% year-on-year decline and a 14.61% sequential drop from Q1 FY26. The Tamil Nadu-based company, with a market capitalisation of ₹164.00 crores, continues to grapple with a dramatic erosion in profitability that has seen its stock plunge 43.87% over the past year, significantly underperforming both the benchmark Sensex and its commodity chemicals sector peers.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Credit Rating
27-Nov-2025 | Source : BSECrisil ratings have reaffirmed the credit rating of the Company as BBB-/Stable (reaffirmed)
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper publication of unaudited financial results (standalone & consolidated) for the quarter and half year ended 30th September 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
13-Nov-2025 | Source : BSEAmendment to inter inter-company loan agreement to the wholly owned subsidiary
Corporate Actions 
No Upcoming Board Meetings
Kanchi Karpooram Ltd has declared 10% dividend, ex-date: 12 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Suresh V Shah (10.4%)
Roop Chand Betala (2.07%)
40.11%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 8.08% vs 6.41% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -14.61% vs 208.45% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -9.26% vs -1.95% in Sep 2024
Growth in half year ended Sep 2025 is -67.44% vs 416.50% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 2.80% vs -33.04% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 844.00% vs -115.54% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 4.02% vs -33.76% in Mar 2024
YoY Growth in year ended Mar 2025 is 2,186.67% vs -95.53% in Mar 2024






